The novel T107I Inherited prion disease can present as a clinical and biomarker mimic of familial Alzheimer’s disease

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Inherited prion diseases (IPD) secondary to mutations of the prion protein gene, PRNP, exhibit diverse clinical phenotypes, capable of mimicking numerous primary neurodegenerative conditions. We describe the clinical phenotype and neuropathological findings in a family from County Limerick in Ireland presenting with Alzheimer’s disease-like cognitive decline and motor symptoms caused by a novel missense mutation of PRNP. This mutation occurs in the PRNP central lysine cluster (CLC; codon 101-110), resulting in substitution of threonine with isoleucine at codon 107 (T107I). This case series highlights that IPD can be hard to distinguish from overlapping clinical syndromes seen in other neurodegenerative diseases. We also discuss similarities and differences of the novel mutation T107I to other pathogenic mutations of the CLC of PRNP.

Cite

CITATION STYLE

APA

Holm-Mercer, L., Coysh, T., Mok, T. H., Rudge, P., Reisz, Z., Troakes, C., … Mead, S. (2025). The novel T107I Inherited prion disease can present as a clinical and biomarker mimic of familial Alzheimer’s disease. Journal of Neurogenetics, 39(1), 16–22. https://doi.org/10.1080/01677063.2024.2440395

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free